kb NB 142-70 (kb NB142-70; kb NB-142-70) is a novel, potent and selective PKD (protein kinase D) inhibitor with anticancer activity.

CID755673 (also known as benzoxoloazepinolone) is a novel, potent and selective cell-active pan-PKD1/2/3 (Protein kinase D) inhibitor with IC50 of 180 nM, 280nM, and 227 nM, respectively, it shows about 200-fold selectivity over other CAMKs.

CRT5(also known as CRT-0066051) is a novel pyrazine benzamide that potent prevents activation of all three isoforms of PKD in endothelial cells treated with VEGF (IC50 s = 1, 2, and 1.5 nM for PKD1, PKD2, and PKD3, respectively).

CID-2011756, discovered from an HTS-high throughput screening campaign, is a cell-permeable, ATP-competitive and specific inhibitor of PKD (protein kinase D) with potential anticancer activity.

CRT 0066101 is a novel, potent and selective inhibitor of protein kinase D (PKD) with IC50 values of 1, 2.5 and 2 nM for PKD1, 2, and 3 respectively.